Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Go back to Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale| (NASDAQ: INDV) | Delayed: 34.94 +0.11 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.83 | 52 Week High | $ | |||
| Open | $34.74 | 52 Week Low | $ | |||
| Day High | $35.31 | P/E | N/A | |||
| Day Low | $34.55 | EPS | $ | |||
| Volume | 1,019,386 | |||||
| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 43.53 -0.44 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.97 | 52 Week High | $26.84 | |||
| Open | $43.66 | 52 Week Low | $9.51 | |||
| Day High | $44.11 | P/E | N/A | |||
| Day Low | $43.43 | EPS | $-2.62 | |||
| Volume | 444,197 | |||||

